Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplements Spared From Melamine “Bombs” – So Far, UNPA’s Israelsen Says

This article was originally published in The Tan Sheet

Executive Summary

The dietary supplement industry has "been lucky," dodging a serious adulteration problem like the melamine contamination that has plagued pet food and infant formula businesses, Loren Israelsen says

You may also be interested in...



USANA Acquires BabyCare For Faster Route To China

Multi-level dietary supplement marketer USANA Health Sciences chooses a faster route over the "arduous" licensing approach to enter China by acquiring nutritional product firm BabyCare Ltd

USANA Acquires BabyCare For Faster Route To China

Multi-level dietary supplement marketer USANA Health Sciences chooses a faster route over the "arduous" licensing approach to enter China by acquiring nutritional product firm BabyCare Ltd

USANA Acquires BabyCare For Faster Route To China

Multi-level dietary supplement marketer USANA Health Sciences chooses a faster route over the "arduous" licensing approach to enter China by acquiring nutritional product firm BabyCare Ltd

Related Content

Topics

UsernamePublicRestriction

Register

OM004634

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel